南美洲和中美洲细胞系开发市场预测至 2027 年 - COVID-19 影响和区域分析(按类型(原代细胞系、杂交瘤、连续细胞系和重组细胞系)、产品(设备、培养基和试剂)、应用(药物发现、生物生产和组织工程)

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 93    |    Report Code: TIPRE00020318    |    Category: Life Sciences

South and Central America Cell Line Development Market

市场介绍

细胞系开发是细胞在受控条件下(大部分在其共同栖息地之外)发育的过程。该细胞系是建立的细胞培养物,当提供生长培养基和生长空间时,其数量会增加无数倍。细胞系开发在医疗保健和生命科学行业有多种应用,例如药物筛选、药物开发、生物生产。不同的细胞可以产生不同的细胞系。细胞系在细胞学研究中起着至关重要的作用。该细胞系能够在定制环境下逐步改变细胞的结构、生理学和基因组成。

 

市场概况和动态

南美洲和中美洲细胞系开发市场预计将从 2019 年的 3.0425 亿美元增至 2027 年的 7.2817 亿美元。预计 2020 年至 2027 年复合年增长率为 11.7%。该市场的增长预计将由于关键驱动因素而增长,例如政府在细胞系开发市场上不断采取的举措以及南美洲和中美洲癌症病例的激增。然而,由于细胞系开发方面存在一些挑战,市场增长可能会受到阻碍。

 

主要细分市场

根据类型,细胞系开发市场分为原代细胞系、杂交瘤、连续细胞细胞系和重组细胞系。根据产品,细胞系开发市场分为设备、媒体和产品。试剂。  根据应用,细胞系开发市场分为 药物发现、生物生产和组织工程。

 

< u>主要来源和列出的公司

报告中包含的细胞系开发市场的一些主要主要和次要来源包括巴西细胞治疗协会 (ABTCel)、国际干细胞应用协会 ( ISSCA)、阿根廷、 和其他

 

购买报告的理由

  • 了解南美洲和中美洲细胞系开发市场格局并确定最有可能保证丰厚回报的细分市场
  • 了解不断变化的竞争格局,保持领先地位细胞系开发市场
  • 通过识别,有效规划南美洲和中美洲细胞系开发市场的并购和合作交易销售潜力最大的细分市场
  • 通过对各种市场表现的敏锐而全面的分析,帮助做出明智的业务决策细胞系开发市场细分
  • 获取南美洲和中美洲各个细分市场 2019 年至 2027 年的市场收入预测地区

 

 

南美洲和中美洲细胞系开发市场细分

 

按类型

·         原代细胞系

< !-- [if !supportLists]-->·         杂交瘤

·        连续细胞系

< !-- [if !supportLists]-->·         重组细胞系

< span lang=\"EN-GB\"> 

按产品

< p class=\"Bullet1-TIP\">·          设备

·        媒体与内容试剂

 

< span lang=\"EN-GB\">按应用

·        药物发现

·        生物生产

·        组织工程

 

按国家/地区

·         ; 南美洲和中美洲

           ·        巴西

           ·        阿根廷

           ·        南美洲和中美洲其他地区

 

公司简介

·   ;       默克公司

·        通用电气

 

·        ;  龙沙



South and Central America Cell Line Development Strategic Insights

Strategic insights for South and Central America Cell Line Development involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-cell-line-development-market-strategic-framework.webp
Get more information on this report

South and Central America Cell Line Development Report Scope

Report Attribute Details
Market size in 2019 US$ 304.25 Million
Market Size by 2027 US$ 728.17 Million
Global CAGR (2020 - 2027) 11.7%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 类型
  • 原代细胞系
  • 杂交瘤
  • 连续细胞系
  • 重组细胞系
By 产品
  • 设备
  • 培养基和试剂
By 应用
  • 药物研发
  • 生物生产
  • 组织工程
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Merck KGaA
  • General Electric
  • Lonza
  • Get more information on this report

    South and Central America Cell Line Development Regional Insights

    The regional scope of South and Central America Cell Line Development refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-cell-line-development-market-geography.webp
    Get more information on this report

    The List of Companies - South and Central America Cell Line Development Market

    1.          Merck KGaA
    2.          General Electric
    3.          Lonza
    Frequently Asked Questions
    How big is the South and Central America Cell Line Development Market?

    The South and Central America Cell Line Development Market is valued at US$ 304.25 Million in 2019, it is projected to reach US$ 728.17 Million by 2027.

    What is the CAGR for South and Central America Cell Line Development Market by (2020 - 2027)?

    As per our report South and Central America Cell Line Development Market, the market size is valued at US$ 304.25 Million in 2019, projecting it to reach US$ 728.17 Million by 2027. This translates to a CAGR of approximately 11.7% during the forecast period.

    What segments are covered in this report?

    The South and Central America Cell Line Development Market report typically cover these key segments-

  • 类型 (原代细胞系, 杂交瘤, 连续细胞系, 重组细胞系)
  • 产品 (设备, 培养基和试剂)
  • 应用 (药物研发, 生物生产, 组织工程)
  • What is the historic period, base year, and forecast period taken for South and Central America Cell Line Development Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Cell Line Development Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in South and Central America Cell Line Development Market?

    The South and Central America Cell Line Development Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Merck KGaA
  • General Electric
  • Lonza
  • Who should buy this report?

    The South and Central America Cell Line Development Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South and Central America Cell Line Development Market value chain can benefit from the information contained in a comprehensive market report.